Cargando…
Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study (KetCRPS-2)
BACKGROUND: Complex regional pain syndrome (CRPS) is a chronic pain condition of an extremity. While achieving pain relief in CRPS is challenging, esketamine infusions can accomplish pain relief for several weeks post-infusion in a subgroup of CRPS patients. Unfortunately, CRPS esketamine protocols...
Autores principales: | Mangnus, Thomas J. P., Dirckx, Maaike, Bharwani, Krishna D., Baart, Sara J., Siepman, Theodora A. M., Redekop, Ken, Dik, Willem A., de Vos, Cecile C., Huygen, Frank J. P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050795/ https://www.ncbi.nlm.nih.gov/pubmed/36991381 http://dx.doi.org/10.1186/s12891-023-06258-4 |
Ejemplares similares
-
Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent Complex Regional Pain Syndrome?
por: Mangnus, Thomas J P, et al.
Publicado: (2023) -
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome
por: Mangnus, Thomas J. P., et al.
Publicado: (2022) -
Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome
por: Bharwani, Krishna D., et al.
Publicado: (2019) -
Effect of intravenous low‐dose S‐ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study
por: Mangnus, Thomas J. P., et al.
Publicado: (2021) -
Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting
por: Bharwani, K. D., et al.
Publicado: (2020)